I think it's still a very important piece of legislation. The importance is the preservation of the eligibility for funding for embryonic stem cell research.
It's a huge victory for people suffering from diseases or injuries.
The market really wants to carry on going up and there is a lot of optimism about this results season. We're not as confident as a lot of others because we think the economic fundamentals are still showing signs of weakness.
There is some real momentum behind the market now, so I think we should see stocks build on their gains.
We have the U.S. reporting season coming up. The key thing here is that there have not been any significant negative pre-announcements, which tells us that expectations have been lowered enough.
We welcome the surprise announcement from the governor, coupled with House Bill 1, which has language that will ensure scientific integrity and ensure this money is given out on a scientific, peer-review basis. It's huge for the community.
You're getting rid of the disease in the bone marrow. I think that the efficacy is unquestionable.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.